Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Insight Public Affairs

We are an award winning 15-strong team of consultants able to offer extensive experience in politics, government, media and stakeholder engagement, across a breadth of policy areas including telecoms, technology, gambling, life sciences, financial services, housing, infrastructure, copyright, employment, media and advertising, food and drink, social care, retail, and education. As an independent agency we go that extra mile to deliver results-focussed communications strategies and programmes that fulfil our clients’ commercial imperatives. Working tirelessly to meet our clients’ goals, we are a team who understand client challenges, develop bespoke strategies and programmes, and meet these strategic objectives.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Health policy and government affairs, Market access, Market research

Company Details

Insight Public Affairs
52 Grosvenor Gardens, London, SW1W 0AU, United Kingdom
+44 (0)20 7824 1865
Contact Insight Public Affairs
Website

 Latest Content from PMHub 

Digital doctors: Talk in 2016

Press Releases | June 27, 2016 | Syneos Health®

The evolving relationship between patient, physician and pharma

How good are your digital sales materials? Just ask these 5 questions

White Papers and Resources | June 15, 2016 | Anthill Agency

Might your sales materials be stuck on step one of the digital technology journey? Consider these five questions to get your answer:

Developing Medical Education That Advances Patient Outcomes

Press Releases | June 15, 2016 | Lucid Group Communications Limited

As pressure mounts on the pharmaceutical industry to demonstrate a tangible and positive impact on patients’ lives, understanding barriers to specific clinician behaviours is key to achieving measurable change in...

Biosimilars – the Brexit of the pharmaceutical industry?

White Papers and Resources | June 14, 2016 | Blue Latitude Health

In this article, Senior Consultant Jenna Earl explains what factors influence the uptake of biosimilars in the UK, comparing them to the same principles that help us navigate the complexities...

Future-proofing with a comprehensive talent development strategy

Press Releases | June 10, 2016 | Lucid Group Communications Limited

Lucid Group is an award-winning group of specialist medical education companies. Over the years, Lucid has developed a strong culture of empowerment, thought-leadership, entrepreneurship and passion to improve outcomes for...

“Most eye-catching” agency Pegasus scoops the ‘EMEA Healthcare PR Consultancy of the Year’ at Sabre Awards

Press Releases | June 10, 2016 | Inizio

Pegasus wins the prestigious “EMEA Healthcare PR Consultancy of the Year” award at the recent Sabre Awards in Berlin, organised by The Holmes Report.

Why isn’t your segmentation working?

White Papers and Resources | June 8, 2016 | Blue Latitude Health

How to develop an actionable segmentation for pharma and healthcare marketing that delivers real commercial value.

Digital is different – why new marketing technologies require new ways of working

White Papers and Resources | June 8, 2016 | Anthill Agency

Digital technology: don’t be afraid to demand more

Creating a better new-to-brand patient experience

White Papers and Resources | June 3, 2016 | Aptus Health

By Robert MacMillan, VP of EHR and Innovation

Research Partnership appoints Director and Head of Business Analytics, North America

White Papers and Resources | June 3, 2016 | Inizio

Tom has been appointed a Director in our Philadelphia office. He has over 25 years’ experience in healthcare research and has an extensive background in both quantitative and qualitative research,...